QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.107.043299v1 73/4/1203    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cherednichenko, G. Articles by Pessah, I. N. Search for Related Content PubMed PubMed Citation Articles by Cherednichenko, G. Articles by Pessah, I. N.

Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene

Department of Molecular Biosciences, University of California, Davis, California (G.C., W.F., E.C., I.N.P.); School of Nursing, University of Maryland, Baltimore, Maryland (C.W.W., L.M.); and Department of Anesthesiology and Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts (J.R.L., M.S., P.D.A.)

Dantrolene is the drug of choice for the treatment of malignant hyperthermia (MH) and is also useful for treatment of spasticity or muscle spasms associated with several clinical conditions. The current study examines the mechanisms of dantrolene's action on skeletal muscle and shows that one of dantrolene's mechanisms of action is to block excitation-coupled calcium entry (ECCE) in both adult mouse flexor digitorum brevis fibers and primary myotubes. A second important new finding is that myotubes isolated from mice heterozygous and homozygous for the ryanodine receptor type 1 R163C MH susceptibility mutation show significantly enhanced ECCE rates that could be restored to those measured in wild-type cells after exposure to clinical concentrations of dantrolene. We propose that this gain of ECCE function is an important etiological component of MH susceptibility and possibly contributes to the fulminant MH episode. The inhibitory potency of dantrolene on ECCE found in wild-type and MH-susceptible muscle is consistent with the drug's clinical potency for reversing the MH syndrome and is incomplete as predicted by its efficacy as a muscle relaxant.

Address correspondence to: Dr. Isaac N. Pessah, Department of Molecular Biosciences, School of Veterinary Medicine, One Shields Avenue, University of California, Davis, CA 95616, E-mail: inpessah{at}ucdavis.edu

This article has been cited by other articles:

				P. B. Rosenberg Calcium entry in skeletal muscle J. Physiol., July 1, 2009; 587(13): 3149 - 3151. [Full Text] [PDF]

				R. T. Dirksen Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle J. Physiol., July 1, 2009; 587(13): 3139 - 3147. [Abstract] [Full Text] [PDF]

				R. A. Bannister, I. N. Pessah, and K. G. Beam The Skeletal L-type Ca2+ Current Is a Major Contributor to Excitation-coupled Ca2+ entry J. Gen. Physiol., December 29, 2008; 133(1): 79 - 91. [Abstract] [Full Text] [PDF]

				A. D. Lyfenko and R. T. Dirksen Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1 J. Physiol., October 15, 2008; 586(20): 4815 - 4824. [Abstract] [Full Text] [PDF]

				D. Jiang, W. Chen, J. Xiao, R. Wang, H. Kong, P. P. Jones, L. Zhang, B. Fruen, and S. R. W. Chen Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia J. Biol. Chem., July 25, 2008; 283(30): 20813 - 20820. [Abstract] [Full Text] [PDF]